Juan Jose Chacon Quiros Net Worth

The estimated Net Worth of Quiros Juan Jose Chacon is at least $13.4 Milhão dollars as of 11 July 2024. Mr Chacon owns over 3,641 units of Establishment Labs Inc stock worth over $8,638,028 and over the last 6 years he sold ESTA stock worth over $4,176,276. In addition, he makes $598,158 as Founder e CEO & Exec. Director at Establishment Labs Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Quiros ESTA stock SEC Form 4 insiders trading

Mr has made over 8 trades of the Establishment Labs Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,641 units of ESTA stock worth $163,991 on 11 July 2024.

The largest trade he's ever made was selling 50,000 units of Establishment Labs Inc stock on 11 January 2021 worth over $2,174,000. On average, Mr trades about 8,214 units every 96 days since 2018. As of 11 July 2024 he still owns at least 210,735 units of Establishment Labs Inc stock.

You can see the complete history of Mr Chacon stock trades at the bottom of the page.

Mr. Juan Jose Chacon Quiros biography

Juan Jose Chacon Quiros is the Founder, CEO & Exec. Director at Establishment Labs Inc.

What is the salary of Mr Quiros?

As the Founder e CEO & Exec. Director of Establishment Labs Inc, the total compensation of Mr Quiros at Establishment Labs Inc is $598,158. There are no executives at Establishment Labs Inc getting paid more.

How old is Mr Quiros?

Mr Quiros is 49, he's been the Founder e CEO & Exec. Director of Establishment Labs Inc since . There are 7 older and 10 younger executives at Establishment Labs Inc. The oldest executive at Establishment Labs Holdings Inc is Dennis Condon, 83, who is the Independent Director.

What's Mr Quiros's mailing address?

Quiros's mailing address filed with the SEC is C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES, DE, 19958.

Insiders trading at Establishment Labs Inc

Over the last 6 years, insiders at Establishment Labs Inc have traded over $8,492,826 worth of Establishment Labs Inc stock and bought 169,894 units worth $9,905,657 . The most active insiders traders include David Hung, Nicholas Sheridan Lewin, eQuiros Juan Jose Chacon. On average, Establishment Labs Inc executives and independent directors trade stock every 34 days with the average trade being worth of $513,072. The most recent stock trade was executed by Quiros Juan Jose Chacon on 11 July 2024, trading 3,641 units of ESTA stock currently worth $163,991.

What does Establishment Labs Inc do?

establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.

Complete history of Mr Chacon stock trades at Establishment Labs Inc

Establishment Labs Inc executives and stock owners

Establishment Labs Inc executives and other stock owners filed with the SEC include:

• Juan Jose Chacon Quiros,
  Founder, CEO & Exec. Director
• Juan Jose Chacon Quiros,
  Chief Executive Officer, Director
• Salvador Santos Dada,
  Chief Operating Officer (Medical Leave of Absence)
• Renee Gaeta,
  Chief Financial Officer
• Salvador Santos,
  Chief Operating Officer
• Eddie De Oliveira,
  Vice President of Sales Latin America
• David Erickson,
  IR Contact Officer
• Edward Schutter,
  Independent Director
• David Hung,
  Independent Director
• Lisa Gersh,
  Independent Director
• Dennis Condon,
  Independent Director
• Lisa Colleran,
  Independent Director
• Jeremy Livianu,
  General Counsel
• Alberto Quesada,
  Vice President - Quality & OUS Regulatory Affairs
• Roberto De Mezerville,
  Chief Technology Officer
• Nicholas Lewin,
  Chairman of the Board
• Roberto de Mezerville,
  Chief Technology Officer
• Rosalyn Cole d'Incelli,
  VP of Clinical & Medical Affairs
• Eddie De Oliveira,
  VP of Sales, Brazil
• Dr. Heather Brennan,
  Head of U.S. Commercial Operations
• Jeffrey Clark Bettinger,
  Global Head of People
• Neeta Toprani,
  Gen. Counsel & Corp. Sec.
• Roberto De Mezerville,
  Chief Technology Officer
• Pratip Dastidar,
  Head of Global Operations
• Rajbir Singh Denhoy,
  CFO and Head of Strategy & Investor Relations
• Paul D. Rodio,
  Chief Operating Officer
• Tu, Lp Cph,
  10% owner
• Asset Management, Llcjw Par...,
  
• Pratip Dastidar,
  Head of Global Operations
• Ann Custin,
  Director
• Bryan Slotkin,
  Director
• Leslie Gillin,
  Director
• Raj Denhoy,
  Chief Financial Officer
• Samuel Ross Mansbach,
  
• Filippo Caldini,
  President